Dr. Cliff Hudis sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) to discuss the challenges in breast cancer clinical trials in the current research landscape. Clifford A. Hudis, MD is the Chief, Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center in New [...]

Dr. Cliff Hudis sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) to discuss tissue collection and genomic testing challenges in breast cancer treatment and research. Clifford A. Hudis, MD is the Chief, Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center in New [...]

Dr. Cliff Hudis sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) where they discuss how advocates and patients can help doctors advance the research for breast cancer. Clifford A. Hudis, MD is the Chief, Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center [...]

Dr. Cliff Hudis discusses electronic medical records and how the system has failed thus far in making this information truly portable and accessible for not only other doctors who need the information, but the patients themselves. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Clifford A. Hudis, [...]

Dr. Cliff Hudis discusses clinical trials and tissue collection in breast cancer research. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Clifford A. Hudis, MD is the Chief, Breast Cancer Medicine at Memorial Sloan-Kettering Cancer Center in New York City. He is a medical oncologist with research [...]

Dr. Cliff Hudis discusses paclitaxel beat two newer chemotherapies—nab-paclitaxel (Abraxane) and ixabepilone (Ixempra)—in the treatment of metastatic breast cancer patients who have not had prior systemic therapies. Paclitaxel fared better in terms of both efficacy and safety compared to the newer agents at the designated doses. This interview was filmed at the American Society of [...]

Dr. Cliff Hudis discuss with data from the T-DM1 EMILIA trial for HER-2 Positive Advanced Breast Cancer presented by Dr. Kimberly Blackwell at ASCO 2012. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Clifford A. Hudis, MD is the Chief, Breast Cancer Medicine at Memorial Sloan-Kettering Cancer [...]

  Dr. Clifford Hudis discusses what’s new with chemotherapy trials at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. He reviews eight posters from the conference that explored various chemotherapy-related questions. Dr. Hudis is the Chief, Breast Cancer Medicine Service at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill-Cornell Medical College [...]

  Dr. Clifford Hudis, through his discussion of the trial showing bevacizumab (Avastin) slows metastatic breast cancer, he highlights the important topic of the value of progression-free survival (PFS). This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Hudis is the Chief, Breast Cancer Medicine Service at Memorial Sloan [...]

  Dr. Clifford Hudis discusses brain metastasis and a clinical trial ongoing at Memorial Sloan Kettering Cancer Center where researchers are testing chemotherapy penetration to the brain in a select group of trial-qualifying patients. This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Hudis is the Chief, Breast Cancer [...]